Keynote Speakers 2019
To be posted soon.
He was the founder and is the coordinator of the ARTS (Advanced Robotics Technologies and Systems) Laboratory and of the CRIM (Center for the Research in Microengineering) Laboratory of the Scuola Superiore Sant’Anna, where he supervises a team of about 120 researchers and PhD. students. He is currently the Director of the Polo Sant’Anna Valdera, the Science Park of the Scuola Superiore Sant’Anna.
His main research interests are in the fields of medical robotics, bio-robotics, mechatronics and micro/nano engineering, and specifically in sensors and actuators for the above applications, and in robotics for rehabilitation. He is the coordinator of many national and European projects, the editor of two books on the subject of robotics, and the author of more than 250 scientific papers (180 on ISI journals).
Endoscopy has become an essential part of clinical gastroenterology and its associated disciplines (hepatology, pancreatology, GI –oncology and visceral surgery). It is the technical discipline in gastroenterology similar to coronary angiography in cardiology. We are currently facing new developments in endoscopy that will facilitate diagnosis and minimally invasive therapy of GI diseases for the sake of our patients.
The digital revolution has brought relevant innovations with respect to early detection and better endoscopic diagnosis. Apart from diagnostic endoscopy, interventional endoscopy is gaining increasing interest; last not least due to the growing public demand for minimal invasiveness. In the near future, more endoscopic intraluminal interventions will therefore be performed necessitating an increasing number of practicing endoscopists.
The boundaries between interventional endoscopy and minimally invasive surgery will dissolve. Moreover, close interaction between physicians, engineers and the biomedical industry is mandatory and will become more and more relevant.
Prof Meining graduated from the Medical School at the University of Saarland and University of Munich in 1997. His areas of expertise are endoscopic diagnosis and treatment of early neoplastic lesions of the GI tract, therapeutic endoscopy of the pancreatico-biliary tract as well as education and training in endoscopy. In 2006, he conducted his research studies for advanced endoscopic techniques in Japan (Showa University, National Cancer Canter, Kitasato East University, Keio University) on invitation of the JESG. He has published more than 150 original research papers. He also released over 50 reviews and letters/case reports. He is also the winner of multiple awards including Ludwig-Demling Grant in 2003 and the ESGE-Innovation-Of-The-Year-Award 2017.
There are many examples of technological innovations in Orthopaedic Surgery. The specialty is well placed for true clinical translation as evidenced by the journey in Knee Surgery from manual instruments to navigation and robotics. The knee joint is perhaps the ideal joint from which to start this revolution due to it’s dependence on a balanced alignment for optimal outcome. This lecture will give a brief insight into the journey and discuss whether finally, with the current Robotic Platforms, we are in a position to deliver systems that are clinically acceptable and ready for mass surgical uptake. Current systems lend themselves well to the concept of “Personalised alignment and customisable shape matching”. This technological advancement and industry development has led to a huge explosion of interest amongst the surgical fraternity and the potential for translation across other musculoskeletal body systems may finally be unlocked. The lecture will explore this journey for a surgeon who has utilised technology to align knee implants throughout his career for all knee replacements since 2005. Early clinical results of the new robot platforms for knee surgery will be discussed and finally a thought of the possible future from a surgeons’ viewpoint.
His main focus is in delivering precise execution of surgical plans and bone conserving knee replacement using technology. He is a programme committee member of the Computer assisted Orthopaedic Surgery (CAOS) International and executive committee member and President Elect of CAOS UK. He is Orthopaedic research advisor for the Hamlyn Centre of Robotics at Imperial College and one of the Key European Opinion Leaders in Robotic Knee Surgery. He is one of the few Surgeons in the UK to have current clinical experience and access to both systems presently available to Orthopaedic Surgeons. He is faculty member on several national and international knee reconstruction course teaching surgeons of all grades including the International Navio cadaveric instructional course in London. He is reviewer for several Orthopaedic Journals including British Bone & Joint Journal, American Journal of Sports Medicine, The Knee, and Injury.
Biological systems are mechanically soft, with complex, time-dependent 3D curvilinear shapes; modern electronic and microfluidic technologies are rigid, with simple, static 2D layouts. Eliminating this profound mismatch in physical properties will create vast opportunities in man-made systems that can intimately integrate with the human body, for diagnostic, therapeutic or surgical function with important, unique capabilities in biomedical research and clinical healthcare. Over the last decade, a convergence of new concepts in materials science, mechanical engineering, electrical engineering and advanced manufacturing has led to the emergence of diverse, novel classes of ‘biocompatible’ electronic and microfluidic systems with skin-like physical properties. This talk describes the key ideas and enabling materials, and it presents some of the most recent device examples, including (1) wireless, skin-like electronic ‘tattoos’ for continuous monitoring of vital signs in neonatal intensive care, (2) microfluidic/electronic platforms that can capture, store and perform biomarker analysis on sweat for sports and fitness and (3) bioresorbable nerve stimulators for accelerated regeneration of damaged peripheral nerves.
His research has been recognized by many awards, including a MacArthur Fellowship (2009), the Lemelson-MIT Prize (2011), and the Smithsonian Award for American Ingenuity in the Physical Sciences (2013) – and most recently the Benjamin Franklin Medal from the Franklin Institute (2019). He is a member of the National Academy of Engineering, the National Academy of Sciences, the National Academy of Inventors and the American Academy of Arts and Sciences.
To be posted soon.
His latest work includes a revolutionary swimming Micro Robot and the new Mazor Renaissance® Brain Surgery. Professor Shoham holds 50 patents and more than a dozen awards, including the recent prestigious 2013 Thomas A. Edison Patent Award and the election into the USA National Academy of Engineering.
To be posted soon.
He is the is the founder of the Harvard Bio-design Lab, which brings together researchers from the engineering, industrial design, apparel, clinical and business communities to develop new disruptive robotic technologies for augmenting and restoring human performance. This research includes new approaches to the design, manufacture and control of wearable robotic devices and characterizing their performance through biomechanical and physiological studies so as to further the scientific understanding of how humans interact with such machines. Example application areas include, enhancing the mobility of healthy individuals, restoring the mobility of patients with gait deficits, assisting those with upper extremity weakness to perform activities of daily living and preventing injuries of workers performing physically strenuous tasks.
Clinical Leaders’ Forum
As part of his sub-specialist development in colorectal surgery he has completed a PhD at Imperial College London. Working with the renowned MERCURY Study Group at The Royal Marsden Hospital, his thesis examined the effect of neoadjuvant chemoradiotherapy on clinical, radiological and molecular aspects of rectal cancer. He remains an active researcher and a recognised academic in rectal cancer with specific interest in imaging and molecular biomarkers. As an academic surgeon, he continues to undertake clinical research and has published more than 75 peer-reviewed articles and book chapters.
In addition to his clinical interests, Mr Chand also holds an MBA degree and has a keen interest in organisational culture and management having completed his dissertation on this subject.
Consultant Laparoscopic, Colorectal & General Surgeon
Queen Alexandra Hospital
Shanghai Chest Hospital, Jiao Tong University, Shanghai, China
Currently, Dr. Luo is the Surgical Director of the Department of Oncology in the Shanghai Chest Hospital. He is an experienced expert in the field of thoracic surgery and has performed over 10,000 operations since he began working. With a particular focus on minimally invasive treatments for lung tumors, Dr. Luo is a pioneer of video and robot-assisted thoracoscopic surgery. In 2009, he completed the first Da Vinci robot-assisted thoracoscopic surgery (RATS) in mainland China and remained the top thoracic surgeon who has performed the most robotic surgeries (over 1,000 till 2018) in China. He now serves as the Vice President of the Chinese Association for Medical Robots (Chinese Medical Doctor Association), Standing Committee Member for the Experts on Minimally Invasive Thoracic Surgery (Chinese Medical Doctor Association), Leader of the Lung Cancer Academic Group of the Shanghai Anti-Cancer Association, as well as many other academic positions.
His main research interests are the diagnosis and treatment of lung cancer and innovation for minimally invasive surgery, especially robotic techniques. He is the author of over 60 original articles published in both Chinese and English and was awarded a utility model invention patent in 2012. He is currently responsible for several international and domestic projects including projects from the National Health and Technology Development Research Center, the International Cooperation Project of the Ministry of Science and Technology, and the Shanghai Science and Technology Commission Fund.
Laparoscopic Kidney and Prostate Cancer Surgery, Kidney Transplantation
Freeman Hospital, Newcastle
Research interest includes renal cancer, renal transplantation and minimally invasive surgery.
Hospital Affiliations: Mount Sinai St. Luke’s and Mount Sinai West, Mount Sinai Queens, The Mount Sinai Hospital, Mount Sinai Beth Israel, New York Eye and Ear Infirmary of Mount Sinai